Richard B. Cannon,
MD
Languages Spoken: English, Spanish
Richard Cannon, MD is a surgeon at the Huntsman Cancer Hospital and assistant professor of Otolaryngology – Head & Neck Surgery at the University of Utah. He is board-certified in Otolaryngology – Head & Neck Surgery and fellowship trained in head and neck surgical oncology, microvascular reconstruction, and advanced robotic surgery by the American Head and Neck Society (AHNS). He performs the full spectrum of head and neck cancer surgery, including diagnosis and treatment of tumors in the mouth, throat, voice box, nose and sinuses, salivary glands, thyroid, and neck. He has additional expertise in microvascular reconstruction following head and neck cancer surgery and minimally invasive robotic surgery for removal of tumors in the throat through the mouth (Transoral Robotic Surgery). He also performs advanced craniofacial trauma and skull base surgery. Dr. Cannon is dedicated to providing each patient with the absolute best possible outcome and treating patients with the same care he would provide members of his own family.
Dr. Cannon graduated cum laude from Pomona College, where he was inducted into the Phi Beta Kappa honor society, followed by medical school at the University of Texas Health Science Center at San Antonio, where he was inducted into the prestigious Alpha Omega Alpha honor medical society. He completed his residency training at the University of Utah, where he held the position of chief resident. He then completed his fellowship training at the University of Washington in Seattle with the world-renowned head and neck cancer and reconstructive surgeon, Neal D. Futran, MD, DMD.
Since completing his training, Dr. Cannon has dedicated himself to advanced reconstructive and oncologic care for patients with head and neck cancer. He is passionate about clinical outcomes research utilizing large national databases, in an effort to improve cancer survival. His research focuses on treatment for head and neck tumors and rehabilitation through surgery. Dr. Cannon has authored numerous studies in medical journals and book chapters, as well as given several national presentations related to living through head and neck cancer with the best functional and quality of life outcomes possible. He serves on the national committees (AAO-HNS) for Head and Neck Surgery and Oncology and (AHNS) Publications. Since his appointment at the University of Utah, he has worked towards improving patient’s outcomes, safety, and satisfaction. He is also on the University of Utah Robotic Surgery committee and currently serves as the medical director of the Huntsman Cancer Hospital’s inpatient surgical floor.
Dr. Cannon has been married to his wife Amy for 7 years and has two wonderful young sons, Cole and Luke. He likes living in the Wasatch Mountains where he enjoys water and snow skiing, biking, hiking, running, and playing soccer.
Clinical Locations
801-587-4566
Board Certification and Academic Information
| Academic Departments | Surgery
-
Assistant Professor (Clinical) |
| Academic Divisions | Otolaryngology-Head and Neck Surgery |
| Board Certification | American Board of Otolaryngology - Head and Neck Surgery |
Patient Rating
The Patient Rating score is an average of all responses to care provider related questions on our nationally-recognized Press Ganey Patient Satisfaction Survey.
Responses are measured on a scale of 1 to 5 with 5 being the best score.
Likelihood of recommending care provider
4.9/ 5
Care provider's explanation of condition/problem
4.9/ 5
Care provider's effort to include me in decisions
4.8/ 5
Wait time at clinic
4.3/ 5
Care provider's concern for questions & worries
4.9/ 5
Patient Comments
Patient comments are gathered from our Press Ganey Patient Satisfaction Survery and displayed in their entirety. Patients are de-identified for confidentiality and patient privacy.
UofU Patient
August 15, 2022
HUNTSMAN CANCER CENTER
#1 doctor on your staff
UofU Patient
August 15, 2022
HUNTSMAN CANCER CENTER
Doctor Cannon spent the time to discuss the options for my cancer situation. He described recovery timelines, pros and cons for each procedure. I felt informed about the decision to have surgery instead of chemo&radiation. Still feel we made the best choice.
UofU Patient
August 12, 2022
HUNTSMAN CANCER CENTER
This was the visit where I feel like I was finally heard about my leg wound not healing. It is frustrating that it took the wound getting to this point (where it smelled bad) for the lack of healing to be taken seriously.
UofU Patient
July 28, 2022
HUNTSMAN CANCER CENTER
I appreciate Dr Cannon. I know he runs behind because he spends a lot of time with his patients. He spent almost 25 minutes with me on this day.
UofU Patient
July 25, 2022
HUNTSMAN CANCER CENTER
Dr. Cannon is the best. Knowledgable and empathetic. If only all doctors were like him!
UofU Patient
July 16, 2022
HUNTSMAN CANCER CENTER
Everything was really great they talked to me in words you can understand and not doctor lingo as most do. He explained everything and showed us everything. The whole staff was very friendly with awesome bedside manor.
UofU Patient
July 11, 2022
HUNTSMAN CANCER CENTER
Very great staff
UofU Patient
July 07, 2022
HUNTSMAN CANCER CENTER
Dr. Richard Cannon and his nurse Tina are awesome!!
UofU Patient
July 05, 2022
HUNTSMAN CANCER CENTER
Best care ever !
UofU Patient
July 04, 2022
HUNTSMAN CANCER CENTER
Dr. Cannon is excellent and gives great health care.
UofU Patient
June 27, 2022
HUNTSMAN CANCER CENTER
Dr. Cannon was so compassionate and informative. I feel like I am in great hands and will certainly be recommending this center.
UofU Patient
June 24, 2022
HUNTSMAN CANCER CENTER
All Good
UofU Patient
June 12, 2022
HUNTSMAN CANCER CENTER
Everything was explained very detailed and was able to ask any questions I had. All concerns were addressed promptly.
UofU Patient
June 07, 2022
HUNTSMAN CANCER CENTER
Dr. Cannon was absolutely amazing and gave me hope after 4 weeks of test and stress. The decision was made that I woukd have surgery and that I would get a call to schedule the surgery. After 2 days of hearing nothing, I left a message for scheduler. It has now been 6 days since my appr with Dr. Cannon and I have heard nothing. Kniwing that the cancer is continuing to grow, my worry is as well. Even a message or call to say they are working on getting it schedule would be appreciated.
UofU Patient
June 04, 2022
HUNTSMAN CANCER CENTER
All good
UofU Patient
May 28, 2022
HUNTSMAN CANCER CENTER
The delays are bad. I like Dr Cannon though and trust him.
UofU Patient
May 16, 2022
HUNTSMAN CANCER CENTER
Overall, good experience.
UofU Patient
May 15, 2022
HUNTSMAN CANCER CENTER
Too soon to tell
UofU Patient
April 04, 2022
HUNTSMAN CANCER CENTER
Good
UofU Patient
March 07, 2022
HUNTSMAN CANCER CENTER
Dr. Cannon and his staff are the best. Staff was very easy to work with especially as I am from out of town. Very accommodating!
UofU Patient
February 16, 2022
HUNTSMAN CANCER CENTER
Dr. Cannon is great.
UofU Patient
February 08, 2022
HUNTSMAN CANCER CENTER
I was so optimistic after my visit however the lack of communication after my visit is draining me Im unable to contact the Dr and it is very frustrating.
UofU Patient
February 05, 2022
HUNTSMAN CANCER CENTER
I have never been treated this good by Doctors and nurses
UofU Patient
January 17, 2022
HUNTSMAN CANCER CENTER
I am happy with my Doctor/patient relationship.
UofU Patient
January 17, 2022
HUNTSMAN CANCER CENTER
They made a difficult situation so much easier just with good communication and making me feel informed and in charge.
UofU Patient
December 16, 2021
HUNTSMAN CANCER CENTER
All Doctors and nurses that we have seen so far have been amazing, Specially Dr. Richard Cannon.Dr. Cannon has been so amazing throughout this process, very informative and has help us so much by giving us confidence.
UofU Patient
December 16, 2021
HUNTSMAN CANCER CENTER
Dr. Cannon is my hero
UofU Patient
November 21, 2021
HUNTSMAN CANCER CENTER
Helped me when I needed it.
UofU Patient
August 22, 2021
HUNTSMAN CANCER CENTER
Dr. Cannon is always kind, professional, and helpful.
UofU Patient
July 20, 2021
HUNTSMAN CANCER CENTER
I get my questions answers I need before I leave , Dr Cannon is very informative .
UofU Patient
July 05, 2021
HUNTSMAN CANCER CENTER
Dr. Cannon is always great. He took a picture of my face to show a fellow Dr. I'm interested in what he finds out.
UofU Patient
June 26, 2021
HUNTSMAN CANCER CENTER
doctor spoke over me entire time and would interrupt me when I was trying to explain symptoms. no empathy asked for complete blood workout to include CBC given symptoms of extreme fatigue and did not complete. asked for PSA test and doctor stated "he would have no idea on how to order"????
UofU Patient
June 21, 2021
HUNTSMAN CANCER CENTER
good
UofU Patient
June 06, 2021
HUNTSMAN CANCER CENTER
Dr. Cannon did not explain recovery expectations and timeline
UofU Patient
May 31, 2021
HUNTSMAN CANCER CENTER
very good explanation of how radiation affected how my skin, and what the options were
UofU Patient
May 13, 2021
HUNTSMAN CANCER CENTER
excellent
UofU Patient
May 13, 2021
HUNTSMAN CANCER CENTER
Dr. Cannon and his staff are ALWAYS kind, considerate, and helpful.
UofU Patient
May 08, 2021
HUNTSMAN CANCER CENTER
he was strait forward and we appreciated that
UofU Patient
May 04, 2021
HUNTSMAN CANCER CENTER
I have always been treated in a kind, professional, and courteous manner.
UofU Patient
April 24, 2021
HUNTSMAN CANCER CENTER
good
UofU Patient
March 30, 2021
HUNTSMAN CANCER CENTER
Enjoyed our visit. He explained everything and answered all questions.
UofU Patient
March 27, 2021
HUNTSMAN CANCER CENTER
Dr. Cannon always takes the time required to iisten and answer all questions during exams. Very nice and compassionate.
UofU Patient
March 25, 2021
HUNTSMAN CANCER CENTER
I was treated in a kind and professional manner by doctor and all staff.
UofU Patient
February 28, 2021
HUNTSMAN CANCER CENTER
Dr. Cannon is the best. I just love that guy. He's been so honest with me regarding my treatments. I trust him completely and feel lucky that he' puts up with me.
UofU Patient
February 20, 2021
HUNTSMAN CANCER CENTER
Dr Cannon instills a great sense of confidence and reduced my anxiety regarding surgery and follow up
UofU Patient
February 03, 2021
HUNTSMAN CANCER CENTER
Everyone was straight forward and to the point. Easy to talk to, and painted a very accurate picture of what to expect and how to proceed. Dr Cannon was absolutely amazing. Gave me options and thoroughly explained all options and what to expect with them
UofU Patient
January 18, 2021
HUNTSMAN CANCER CENTER
Dr Cannon has a great bedside manner. He was able to be direct and informative in concerning time, without making it uncomfortable. He was open to questions and took the time to explain the pros and cons along the whys behind how moms condition her treatment options.
UofU Patient
December 12, 2020
HUNTSMAN CANCER CENTER
very good with the information
UofU Patient
December 07, 2020
HUNTSMAN CANCER CENTER
This is the very best experience I have ever had with a hospital and medical professionals.
UofU Patient
December 05, 2020
HUNTSMAN CANCER CENTER
Epic people.
Richard Cannon, MD is a surgeon at the Huntsman Cancer Hospital and assistant professor of Otolaryngology – Head & Neck Surgery at the University of Utah. He is board-certified in Otolaryngology – Head & Neck Surgery and fellowship trained in head and neck surgical oncology, microvascular reconstruction, and advanced robotic surgery by the American Head and Neck Society (AHNS). He performs the full spectrum of head and neck cancer surgery, including diagnosis and treatment of tumors in the mouth, throat, voice box, nose and sinuses, salivary glands, thyroid, and neck. He has additional expertise in microvascular reconstruction following head and neck cancer surgery and minimally invasive robotic surgery for removal of tumors in the throat through the mouth (Transoral Robotic Surgery). He also performs advanced craniofacial trauma and skull base surgery. Dr. Cannon is dedicated to providing each patient with the absolute best possible outcome and treating patients with the same care he would provide members of his own family.
Dr. Cannon graduated cum laude from Pomona College, where he was inducted into the Phi Beta Kappa honor society, followed by medical school at the University of Texas Health Science Center at San Antonio, where he was inducted into the prestigious Alpha Omega Alpha honor medical society. He completed his residency training at the University of Utah, where he held the position of chief resident. He then completed his fellowship training at the University of Washington in Seattle with the world-renowned head and neck cancer and reconstructive surgeon, Neal D. Futran, MD, DMD.
Since completing his training, Dr. Cannon has dedicated himself to advanced reconstructive and oncologic care for patients with head and neck cancer. He is passionate about clinical outcomes research utilizing large national databases, in an effort to improve cancer survival. His research focuses on treatment for head and neck tumors and rehabilitation through surgery. Dr. Cannon has authored numerous studies in medical journals and book chapters, as well as given several national presentations related to living through head and neck cancer with the best functional and quality of life outcomes possible. He serves on the national committees (AAO-HNS) for Head and Neck Surgery and Oncology and (AHNS) Publications. Since his appointment at the University of Utah, he has worked towards improving patient’s outcomes, safety, and satisfaction. He is also on the University of Utah Robotic Surgery committee and currently serves as the medical director of the Huntsman Cancer Hospital’s inpatient surgical floor.
Dr. Cannon has been married to his wife Amy for 7 years and has two wonderful young sons, Cole and Luke. He likes living in the Wasatch Mountains where he enjoys water and snow skiing, biking, hiking, running, and playing soccer.
Academic Locations
School of Medicine
801-587-3888
(801) 585-7288
Research Statement
Richard Cannon, MD is a surgeon at the Huntsman Cancer Hospital and assistant professor of Otolaryngology – Head & Neck Surgery at the University of Utah. He is board-certified in Otolaryngology – Head & Neck Surgery and fellowship trained in head and neck surgical oncology, microvascular reconstruction, and advanced robotic surgery by the American Head and Neck Society (AHNS). He performs the full spectrum of head and neck cancer surgery, including diagnosis and treatment of tumors in the mouth, throat, voice box, nose and sinuses, salivary glands, thyroid, and neck. He has additional expertise in microvascular reconstruction following head and neck cancer surgery and minimally invasive robotic surgery for removal of tumors in the throat through the mouth (Transoral Robotic Surgery). He also performs advanced craniofacial trauma and skull base surgery. Dr. Cannon is dedicated to providing each patient with the absolute best possible outcome and treating patients with the same care he would provide members of his own family.
Dr. Cannon graduated cum laude from Pomona College, where he was inducted into the Phi Beta Kappa honor society, followed by medical school at the University of Texas Health Science Center at San Antonio, where he was inducted into the prestigious Alpha Omega Alpha honor medical society. He completed his residency training at the University of Utah, where he held the position of chief resident. He then completed his fellowship training at the University of Washington in Seattle with the world-renowned head and neck cancer and reconstructive surgeon, Neal D. Futran, MD, DMD.
Since completing his training, Dr. Cannon has dedicated himself to advanced reconstructive and oncologic care for patients with head and neck cancer. He is passionate about clinical outcomes research utilizing large national databases, in an effort to improve cancer survival. His research focuses on treatment for head and neck tumors and rehabilitation through surgery. Dr. Cannon has authored numerous studies in medical journals and book chapters, as well as given several national presentations related to living through head and neck cancer with the best functional and quality of life outcomes possible. He serves on the national committees (AAO-HNS) for Head and Neck Surgery and Oncology and (AHNS) Publications. Since his appointment at the University of Utah, he has worked towards improving patient’s outcomes, safety, and satisfaction. He is also on the University of Utah Robotic Surgery committee and currently serves as the medical director of the Huntsman Cancer Hospital’s inpatient surgical floor.
Dr. Cannon has been married to his wife Amy for 7 years and has two wonderful young sons, Cole and Luke. He likes living in the Wasatch Mountains where he enjoys water and snow skiing, biking, hiking, running, and playing soccer.
Board Certification and Academic Information
| Academic Departments | Surgery
-
Assistant Professor (Clinical) |
| Academic Divisions | Otolaryngology-Head and Neck Surgery |
| Board Certification | American Board of Otolaryngology - Head and Neck Surgery |
Education History
| Fellowship | University of Washington School of Medicine Head and Neck Surgical Oncology with Microvascular Reconstruction and Advanced Robotic Surgery Fellow, 2017 |
| Chief Resident | University of Utah School of Medicine Otolaryngology Chief Resident, 2016 |
| Residency | University of Utah School of Medicine Otolaryngology Resident, 2015 |
| Professional Medical | University of Texas Health Science Center at San Antonio Medicine M.D., 2011 |
| Undergraduate | Pomona College Major: Biology; Minor: Mathematics B.A., 2005 |
Selected Publications - Journal Articles
Journal Article
- Hu B, Patel JL, Tao R, Cannon RB, Monroe M, Goyal G (2022). Near Complete Response to Trametinib Treatment in Histiocytic Sarcoma Harboring a Somatic KRAS Mutation. J Natl Compr Canc Netw, 1-4.
- Fenlon JB, Hutten RJ, Weil CR, Lloyd S, Cannon DM, Kerrigan K, Cannon RB, Hitchcock YJ (2021). Comparing adjuvant radiation to adjuvant chemoradiation in postsurgical p16+ oropharyngeal carcinoma patients with extranodal extension or positive margins. Head Neck, 44(3), 606-614.
- Carpenter P, McCrary HC, Aylward A, Cerrati E, Hunt JP, Buchmann LO, Cannon RB (2021). Penetrating Trauma Rapid Estimated Disability Scale: Assessing Facial Self-Inflicted Gunshot Wounds. Facial Plast Surg Aesthet Med, 23(6), 455-459.
- McCrary HC, McLean SR, Luman A, OSullivan P, Smith B, Cannon RB (2021). A National Survey of Robotic Surgery Training Among Otolaryngology-Head and Neck Surgery Residents. Ann Otol Rhinol Laryngol, 130(9), 1085-1092.
- Cash H, Harbison RA, Futran N, Parvathaneni U, Laramore GE, Liao J, Cannon R, Rodriguez C, Houlton JJ (2020). Neutron Therapy for High-Grade Salivary Carcinomas in the Adjuvant and Primary Treatment Setting. Laryngoscope, 131(3), 541-547.
- McCrary HC, Newberry CI, Casazza GC, Cannon RB, Ramirez AL, Meier JD (2020). Evaluation of opioid prescription patterns among patients undergoing thyroid surgery. Head Neck, 43(3), 903-908.
- Harbison RA, Gray AJ, Westling T, Carone M, Rodriguez CP, Futran ND, Cannon RB, Houlton J (2019). The role of elective neck dissection in high-grade parotid malignancy: A hospital-based cohort study. Laryngoscope, 130(6), 1487-1495.
- Aylward A, Park J, Abdelaziz S, Hunt JP, Buchmann LO, Cannon RB, Rowe K, Snyder J, Deshmukh V, Newman M, Wan Y, Fraser A, Smith K, Lloyd S, Hitchcock Y, Hashibe M, Monroe MM (2020). Individualized prediction of late-onset dysphagia in head and neck cancer survivors. Head Neck, 42(4), 708-718.
- McCrary HC, Cannon RB, Buchmann LO (2019). Some Considerations in Treating Malignant Head and Neck Paragangliomas-Reply. JAMA Otolaryngol Head Neck Surg, 146(2), 210-211.
- Aylward A, Abdelaziz S, Hunt JP, Buchmann LO, Cannon RB, Lloyd S, Hitchcock Y, Hashibe M, Monroe MM (2019). Rates of Dysphagia-Related Diagnoses in Long-Term Survivors of Head and Neck Cancers. Otolaryngol Head Neck Surg, 161(4), 643-651.
- McCrary HC, Babajanian E, Calquin M, Carpenter P, Casazza G, Naumer A, Greenberg S, Kohlmann W, Cannon R, Monroe MM, Hunt JP, Buchmann L (2019). Characterization of Malignant Head and Neck Paragangliomas at a Single Institution Across Multiple Decades. JAMA Otolaryngol Head Neck Surg, 145(7), 641-646.
- Cannon RB, Kull AJ, Carpenter PS, Francis S, Buchmann LO, Monroe MM, Lloyd S, Hitchcock YJ, Cannon D, Weis JR, Houlton JJ, Hunt JP (2019). Adjuvant radiation for positive margins in adult head and neck sarcomas is associated with improved survival: Analysis of the National Cancer Database. Head Neck, 41(6), 1873-1879.
- Gobillot TA, Kaka AS, Patel SA, Rodriguez C, Cannon RB, Futran ND, Houlton JJ (2018). Treatment of Tonsillar Carcinoma following Nononcologic Tonsillectomy: Efficacy of Transoral Robotic Revision Tonsillectomy. Otolaryngol Head Neck Surg, 160(4), 627-634.
- Dundar Y, Cannon R, Wiggins R, Monroe MM, Buchmann LO, Hunt JP (2018). Orbital invasion routes of non-melanoma skin cancers and survival outcomes. Orbit, 37(6), 405-410.
- Carpenter PS, Shepherd HM, McCrary H, Torrecillas V, Kull A, Hunt JP, Monroe MM, Buchmann LO, Cannon RB (2018). Association of Celecoxib Use With Decreased Opioid Requirements After Head and Neck Cancer Surgery With Free Tissue Reconstruction. JAMA Otolaryngol Head Neck Surg, 144(11), 988-994.
- Cannon RB, Shepherd HM, McCrary H, Carpenter PS, Buchmann LO, Hunt JP, Houlton JJ, Monroe MM (2018). Association of the Patient Protection and Affordable Care Act With Insurance Coverage for Head and Neck Cancer in the SEER Database. JAMA Otolaryngol Head Neck Surg, 144(11), 1052-1057.
- Cannon RB, Houlton JJ, Patel S, Raju S, Noble A, Futran ND, Parvathaneni U, Mndez E (2018). Patterns of cervical node positivity, regional failure rates, and fistula rates for HPV+ oropharyngeal squamous cell carcinoma treated with transoral robotic surgery (TORS). Oral Oncol, 86, 296-300.
- Torrecillas V, Shepherd HM, Francis S, Buchmann LO, Monroe MM, Lloyd S, Cannon D, Hitchcock YJ, Weis JR, Hunt JP, Houlton JJ, Cannon RB (2018). Adjuvant radiation for T1-2N1 oral cavity cancer survival outcomes and utilization treatment trends: Analysis of the SEER database. Oral Oncol, 85, 1-7.
- Cannon RB, Carpenter PS, Boothe D, Buchmann LO, Hunt JP, Lloyd S, Hitchcock YJ, Houlton JJ, Weis JR, Shepherd HM, Monroe MM (2018). Academic Facility Utilization and Survival Outcomes in Adult Head and Neck Sarcomas: An NCDB Analysis. Otolaryngol Head Neck Surg, 159(3), 473-483.
- Dundar Y, Cannon RB, Hunt JP, Monroe M, Suneja G, Hitchcock YJ (2018). Radiotherapy regimens in patients with nonmelanoma head and neck skin cancers. Int J Dermatol, 57(4), 441-448.
- Thomas AJ, Larson MO, Braden S, Cannon RB, Ward PD (2017). Effect of 3 Commercially Available Botulinum Toxin Neuromodulators on Facial Synkinesis: A Randomized Clinical Trial. JAMA Facial Plast Surg, 20(2), 141-147.
- Cannon RB, Houlton JJ, Mendez E, Futran ND (2017). Methods to reduce postoperative surgical site infections after head and neck oncology surgery. Lancet Oncol, 18(7), e405-e413.
- Sowder JC, Cannon RB, Buchmann LO, Hunt JP, Hitchcock Y, Lloyd S, Grossmann KF, Monroe MM (2017). Treatment-related determinants of survival in early-stage (T1-2N0M0) oral cavity cancer: A population-based study. Head Neck, 39(5), 876-880.
- Dundar Y, Cannon RB, Monroe MM, Buchmann LO, Hunt JP (2016). Skull Base Invasion Patterns and Survival Outcomes of Nonmelanoma Skin Cancers. J Neurol Surg B Skull Base, 78(2), 164-172.
- Cannon RB, Dundar Y, Thomas A, Monroe MM, Buchmann LO, Witt BL, Sowder AM, Hunt JP (2017). Elective Neck Dissection for Head and Neck Cutaneous Squamous Cell Carcinoma with Skull Base Invasion. Otolaryngol Head Neck Surg, 156(4), 671-676.
- Cannon RB, Wiggins RH 3rd, Witt BL, Dundar Y, Johnston TM, Hunt JP (2017). Imaging and Outcomes for a New Entity: Low-Grade Sinonasal Sarcoma with Neural and Myogenic Features. J Neurol Surg Rep, 78(1), e15-e19.
- Cannon RB, Sowder JC, Buchmann LO, Hunt JP, Hitchcock YJ, Lloyd S, Grossman KF, Monroe MM (2017). Increasing use of nonsurgical therapy in advanced-stage oral cavity cancer: A population-based study. Head Neck, 39(1), 82-91.
- Cannon RB, Thomson RS, Shelton C, Gurgel RK (2016). Long-term Outcomes After Middle Fossa Approach for Traumatic Facial Nerve Paralysis. Otol Neurotol, 37(6), 799-804.
- Buchmann L, Ashby S, Cannon RB, Hunt JP (2015). Psychosocial distress in patients with thyroid cancer. Otolaryngol Head Neck Surg, 152(4), 644-9.
- Cannon RB, Gurgel RK, Warren FM, Shelton C (2015). Facial nerve outcomes after middle fossa decompression for Bell's palsy. Otol Neurotol, 36(3), 513-8.
Book Chapter
- Hunt JP, Cannon RB (2016). Parathyroid Carcinoma. In David JT, William D (Eds.), Thyroid and Parathyroid Diseases: Medical and Surgical Management (2nd Edition). Thieme Medical Publishers, Inc.
- Cannon RB, McCrary HC, Sharma J, Carpenter PS (). Infection Peri Microsurgical Head and Neck Reconstruction. In Wei FC, El Deek N, Meningaud JP, Futran ND (Eds.), Mastery of Microsurgical Reconstruction of the Head and Neck. New York, NY: Thieme Medical Publishers, Inc.
- McCrary HC, Monroe MM, Cannon RB (). Head and Neck Neoplasms. In Karsy M, Abou-Al-Shaar H, Guan J, and Nirula R (Eds.), The Surgical Handbook (pp. 144-152). New York, NY: Thieme Medical Publishers, Inc.
- Babajanian E, McCrary HC, Cannon RB (). Airway Management/Tracheostomy. In Karsy M, Abou-Al-Shaar H, Guan J, and Nirula R (Eds.), The Surgical Handbook (pp. 101-108). New York, NY: Thieme Medical Publishers, Inc.
Case Report
- Cohen MA, Cannon RB, Couldwell WT (2020). Resection of Invasive Sphenoorbital and Cavernous Sinus Meningioma via Frontotemporal Craniotomy. World Neurosurg, 141, 252.
- Cannon RB, Wiggins RH 3rd, Witt BL, Dundar Y, Johnston TM, Hunt JP (2017). Imaging and Outcomes for a New Entity: Low-Grade Sinonasal Sarcoma with Neural and Myogenic Features. J Neurol Surg Rep, 78(1), e15-e19.
Letter
- McCrary HC, Cannon RB, Buchmann LO (2019). Response Regarding Characterization of Malignant Head and Neck Paragangliomas at a Single Institution Across Multiple Decades [Letter to the editor]. JAMA Otolaryngol Head Neck Surg.
- Cannon RB, Shelton C, Gurgel RK (2017). Response Regarding Combined Transmastoid and Middle Fossa Approach. [Letter to the editor]. Otol Neurotol, 38(2), 304.
Other
- Fenlon JB, Hutten RJ, Weil CR, Lloyd S, Cannon DM, Kerrigan K, Cannon RB, Hitchcock YJ (2021). Comparing adjuvant radiation to adjuvant chemoradiation in postsurgical p16+ oropharyngeal carcinoma patients with extranodal extension or positive margins. Head Neck (44(3), pp. 606-614). United States.
- Dundar Y, Cannon RB, Monroe MM, Buchmann LO, Hunt JP (2016). Erratum: Skull Base Invasion Patterns and Survival Outcomes of Nonmelanoma Skin Cancers. J Neurol Surg B Skull Base (78(2), pp. e2-e4). Germany.